...
机译:DNA修复基因MLH1 MLH1的表达与切除胰腺癌的患者的存活率相关,并接受了佐剂化学校长:NRG肿瘤学研究9704
Department of Oncology Chaim Sheba Medical Center Sackler School of MedicineTel Aviv;
Statistics and Data Management Center NRG OncologyPhiladelphia Pennsylvania;
Department of Anatomic PathologyH. Lee Moffitt Cancer CenterTampa Florida;
Boehringer Ingelheim PharmaceuticalsRidgefield Connecticut;
University of Maryland School of MedicineBaltimore Maryland;
Toledo Clinic Cancer CentersToledo Ohio;
Department of Radiation OncologyRhode Island Hospital/The Warren Alpert Medical School of Brown;
Department of Radiation OncologyLoyola University Medical CenterChicago Illinois;
Department of PathologyUniversity of California‐San Francisco Medical CenterSan Francisco California;
Department of Oncology Chaim Sheba Medical Center Sackler School of MedicineTel Aviv;
Statistics and Data Management Center NRG OncologyPhiladelphia Pennsylvania;
Department of Radiation OncologyMontefiore Medical CenterBronx New York;
Memorial Sloan Kettering Cancer CenterNew York New York;
Department of Radiation OncologySidney Kimmel Medical College at Thomas Jefferson;
biomarkers; chemotherapy; adjuvant; clinical trial phase 3; mutL protein homolog 1 (MLH1); pancreatic neoplasms; radiotherapy; adjuvant; tumor;
机译:DNA修复基因MLH1 MLH1的表达与切除胰腺癌的患者的存活率相关,并接受了佐剂化学校长:NRG肿瘤学研究9704
机译:可重置胰腺癌患者的婚姻状况和整体生存:NRG肿瘤学的辅助分析结果9704
机译:切除后CA 19-9预测了接受辅助化学放疗的胰腺癌患者的总体生存:RTOG 9704的前瞻性验证。
机译:DNA修复基因MLH1的表达与接受辅助放化疗的切除胰腺癌的存活率相关:NRG Oncology RTOG 9704
机译:切除后CA 19-9预测接受辅助化学放射治疗的胰腺癌患者的总体生存:RTOG 9704的前瞻性验证